Qingxian Cai
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 2
- Neurology top 2%
- Hepatology top 5%
- Hepatitis C virus research 10
- Liver Disease and Transplantation 3
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 11
- Hepatitis B Virus Studies 9
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 2
-
- Immune Cell Function and Interaction 3
- Co-authors
- Jun ChenQing HeLin XuYingxia LiuDeliang HuangLei LiuYinan SuXia Zhang
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qingxian Cai
29 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Infectious Diseases 1.4k
- Neurology 709
- Hepatology 180
- Epidemiology 552
- Pharmacology 101
Countries citing papers authored by Qingxian Cai
This map shows the geographic impact of Qingxian Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingxian Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingxian Cai more than expected).
Fields of papers citing papers by Qingxian Cai
This network shows the impact of papers produced by Qingxian Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingxian Cai. The network helps show where Qingxian Cai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingxian Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 2 | |
| 9 | Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, Chinabreakdown → | 2020 | 483 |
| 10 | COVID-19: Abnormal liver function testsbreakdown → | 2020 | 708 |
| 11 | COVID‐19 in a designated infectious diseases hospital outside Hubei Province, Chinabreakdown → | 2020 | 372 |
| 12 | 2020 | 10 | |
| 13 | 2020 | 11 | |
| 14 | 2017 | 11 | |
| 15 | 2016 | 3 | |
| 16 | 2014 | 7 | |
| 17 | 2012 | 61 | |
| 18 | 2012 | 17 | |
| 19 | 2011 | 8 | |
| 20 | 2011 | 1 |
About Qingxian Cai
Qingxian Cai is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 29 papers that have together received 1.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers), COVID-19 Clinical Research Studies (6 papers), Immune Cell Function and Interaction (3 papers), Liver Disease and Transplantation (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Neurology (709 citations) and Hepatology (180 citations). Qingxian Cai has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jun Chen, Qing He, Lin Xu, Yingxia Liu, Deliang Huang, Lei Liu, Yinan Su, Xia Zhang, Zhibin Zhu and Guangde Zhou. Their work appears in journals such as Diabetes Care, Journal of Hepatology and Materials Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.